Brief: Broadwood Partners - Publishes Presentation Detailing Opposition To Staar Surgical's Sale To Alcon
Oct 3 (Reuters) - BROADWOOD PARTNERS: PUBLISHES PRESENTATION DETAILING OPPOSITION TO STAAR SURGICAL'S SALE TO ALCON BELIEVES TRANSACTION COMES AT WRONG TIME, AFTER WRONG PROCESS, AND AT WRONG PRICE WE BELIEVE THAT THERE WAS NO COMPELLING REASON TO SELL STAAR AT THIS TIME URGES ALL STOCKHOLDERS TO VOTE "AGAINST" PROPOSED MERGER Source text: ID:nBw6cSm47a Further company coverage: ALCC.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alcon AG
See all newsBrief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Brief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Swiss stocks - Factors to watch on October 19
Brief: FDA Approves Alcon’S BRYTL Eye Drops
Advisory: Alert incorrectly tagged to Omega Interactive Technologies withdrawn